Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study-Reference-Cited by-同舟云学术

Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study

Published:2021-09-02 Issue:6 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Mastorino Luca¹^ORCID,Viola Riccardo¹,Panzone Michele¹,Avallone Gianluca¹,Gallo Giuseppe¹,Ortoncelli Michela¹,Cavaliere Giovanni¹,Quaglino Pietro¹,Ribero Simone¹^ORCID

Affiliation:

1. Medical Science Department, Section of Dermatology University of Turin Turin Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15115

Reference9 articles.

1. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS

2. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

3. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

4. Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists and Public Health (ADOI), the Italian Association of Hospital and Territorial Allergists and immunologists (AAIITO), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), the Italian Society of Pediatric Allergy and Immunology (SIAIP), the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA), and the Italian Society of Pediatric Dermatology (SIDerP);Calzavara‐Pinton P;Ital J Dermatol Venerol,2021

5. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real‐life Italian tertiary centre experience

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predisposition to conjunctivitis and male sex reduces drug survival of dupilumab in adults and adolescents;Expert Opinion on Biological Therapy;2024-06-25

2. Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up;Journal of Asthma and Allergy;2024-04

3. A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children;Drug Design, Development and Therapy;2024-03

4. Integrative Approaches to Sleep Management in Skin Disease: Systematic Review;JMIR Dermatology;2023-12-13

5. Two Cases of Immune Drift Phenomena Caused by Biologic Agents for Treating Psoriasis and Atopic Dermatitis;Clinical, Cosmetic and Investigational Dermatology;2023-12